Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

01. April 2019 07:00 ET | Quelle: Valeritas, Inc.

Valeritas partners with the American Association of Diabetes Educators (AADE)

BRIDGEWATER, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
28. März 2019 07:00 ET | Quelle: Valeritas, Inc.

Valeritas Announces V-Go® Distribution Agreement in Israel

BRIDGEWATER, N.J., March 28, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
12. März 2019 07:00 ET | Quelle: Valeritas, Inc.

Valeritas to Present at the Oppenheimer 29th Annual Healthcare Conference

BRIDGEWATER, N.J., March 12, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
05. März 2019 16:05 ET | Quelle: Valeritas, Inc.

Valeritas Reports Fourth Quarter and Full Year 2018 Financial Results

BRIDGEWATER, N.J., March 05, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
28. Februar 2019 16:05 ET | Quelle: Valeritas, Inc.

Valeritas Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

BRIDGEWATER, N.J., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
21. Februar 2019 07:00 ET | Quelle: Valeritas, Inc.

Switching to Valeritas’ V-Go® Wearable Insulin Delivery Device from Insulin Pen Devices for Basal-Bolus Therapy Improved Glycemic Control with Less Insulin

BRIDGEWATER, N.J., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
19. Februar 2019 07:00 ET | Quelle: Valeritas, Inc.

Valeritas to Present at Upcoming Investor Conferences

BRIDGEWATER, N.J., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
12. Februar 2019 07:00 ET | Quelle: Valeritas, Inc.

Valeritas to Report Fourth Quarter and Full Year 2018 Financial Results on March 5, 2019

BRIDGEWATER, N.J., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
14. Januar 2019 07:00 ET | Quelle: Valeritas, Inc.

Valeritas Announces V-Go® Received Preferred Status on OptumRx Formularies

BRIDGEWATER, N.J., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
03. Januar 2019 07:07 ET | Quelle: Valeritas, Inc.

Valeritas Announces V-Go® is Preferred on Humana Part D Formularies

BRIDGEWATER, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, affordable,...

Vorherige Seite

Nächste Seite